Skip to main content
. 2018 Nov 22;9:1371. doi: 10.3389/fphar.2018.01371

FIGURE 3.

FIGURE 3

Ferroptosis contributes to RSL3-induced growth inhibition in CRC cells. (A) HCT116 cells were treated with RSL3 with or without the indicated inhibitors for 24 h and cell viability was assayed (n = 3, p < 0.05 versus RSL3 treatment group); (B) HT29 cells were treated with RSL3 with or without the indicated inhibitors for 24 h and cell viability was assayed (n = 3, p < 0.05 versus RSL3 treatment group). (C) LoVo cells were treated with RSL3 with or without the indicated inhibitors for 24 h and cell viability was assayed (n = 3, p < 0.05 versus RSL3 treatment group).